COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 899: Articles 8981-8990  | Next

Association of COVID-19 with risks of hospitalization and mortality from other disorders post-infection: A study of the UK Biobank
XIANG, Y., ZHANG, R., QIU, J., So, H.-C.
10.1101/2022.03.23.22272811 — Posted: 2022-03-23
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial.
Nguyen, T. P., Do, Q., Phan, L. T., Anh, D. D., Khong, H., Dinh, D. V., Hoang, L. V., Nguyen, T. V., Pham, H. N., Chu, M. V., Nguyen, T. T., Le, T. M., Trang, T. T. N., Dinh, T. T., Vo, T. V., Vu, T. T., Nguyen, Q. B. P., Phan, V. T., Nguyen, L. V., Nguyen, G. T., Tran, P. M., Nghiem, T. D., Tran, T. V., Nguyen, T. G., Tran, T. Q., Nguyen, L. T., Do, A. T., Nguyen, D. D., Ho, S. A., Nguyen, V. T., Pham, D. T., Tran, H. B., Vu, S. T., Hoang, S. X., Do, T. M., Nguyen, X. T., Le, G. Q., Tran, T., Cao, T. M., Dao, H. M., Nguyen, T. T. T., Doan, U. Y., Le, V. T. T., Tran, L. P., Nguyen, N. M., Nguyen, N. T., Pham, H. T. T., Nguyen, Q. H., Pham, Q. D., Nguyen, H. T., Nguyen, H. L. K., Trang, N. V., Nguyen, L. A. T., Nguyen, L. T., Trinh, N. T. H., Le, L. T. K., Tran, V. T. B., Chu, M. T. N., Phan, M. H., Nguyen, H. T. H., Tran, V. T., Tran, M. T. N., Nguyen, T. T. T., Ha, P. T., Huynh, H. T., Nguyen, K. D., Ung, T. T., Duong, N. H. T., Doan, C. C., Do, S. M.
10.1101/2022.03.22.22272739 — Posted: 2022-03-23
SCENTinel 1.1 rapidly screens for COVID-19 related olfactory disorders
Hunter, S. R., Hannum, M. E., Pellegrino, R., O'Leary, M. A., Rawson, N. E., Reed, D. R., Dalton, P. H., Parma, V.
10.1101/2022.03.23.22272807 — Posted: 2022-03-23
Research on the Emotions of Uninfected People during the COVID-19 Epidemic in China
Chen, G., Yue, J.-J.
10.1101/2022.03.22.22272730 — Posted: 2022-03-23
Risk of death following SARS-CoV-2 infection or COVID-19 vaccination in young people in England: a self-controlled case series study
Nafilyan, V., Bermingham, C., Ward, I. L., Morgan, J., Zaccardi, F., Khunti, K., Stanborough, J., Banerjee, A.
10.1101/2022.03.22.22272775 — Posted: 2022-03-23
Performance of Gazelle COVID-19 point-of-care test for detection of nucleocapsid antigen from SARS-CoV-2
Mehta, A., Spencer, B., Garg, A., Kalmorge, P., Gonzalez, R. A. O., Taussig, K., Fortna, R. R.
10.1101/2022.03.23.22272094 — Posted: 2022-03-23
Mathematical modelling of COVID-19 transmission dynamics with vaccination: A case study in Ethiopia
Sharbayta, S. S., Desta, H. D., Abdi, T.
10.1101/2022.03.22.22272758 — Posted: 2022-03-23
Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients
Meister, T. L., Dreismeier, M., Vidal Blanco, E., Brueggemann, Y., Heinen, N., Kampf, G., Todt, D., Nguyen, H. P., Steinmann, J., Schmidt, W. E., Steinmann, E., Quast, D. R., Pfaender, S.
10.1101/2022.03.22.22272773 — Posted: 2022-03-23
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
Lapointe, H. R., Mwimanzi, F., Cheung, P. K., Sang, Y., Yaseen, F., Umviligihozo, G., Kalikawe, R., Speckmaier, S., Moran-Garcia, N., Datwani, S., Duncan, M. C., Agafitei, O., Ennis, S., Young, L., Ali, H., Ganase, B., Omondi, F. H., Dong, W., Toy, J., Sereda, P., Burns, L., Costiniuk, C. T., Cooper, C., Anis, A., Leung, V., Holmes, D. T., DeMarco, M. L., Simons, J., Hedgcock, M., Prystajecky, N., Lowe, C. F., Pantophlet, R., Romney, M. G., Barrios, R., Guillemi, S., Brumme, C. J., Montaner, J. S. G., Hull, M., Harris, M., Niikura, M., Brockman, M. A., Brumme, Z. L.
10.1101/2022.03.22.22272793 — Posted: 2022-03-23
A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
Chen, C., Boorla, V. S., Chowdhury, R., Nissly, R. H., Gontu, A., Chothe, S. K., LaBella, L., Jakka, P., Ramasamy, S., Vandegrift, K. J., Surendran Nair, M., Kuchipudi, S. V., Maranas, C. D.
10.1101/2022.03.22.485413 — Posted: 2022-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).